Cannabidiol monotherapy for treatment-resistant schizophrenia (2006)
Source: Journal of Phychopharmacology. Unidade: FMRP
Assunto: ESQUIZOFRENIA
ABNT
ZUARDI, Antonio Waldo et al. Cannabidiol monotherapy for treatment-resistant schizophrenia. Journal of Phychopharmacology, v. 20, n. 5, p. 683-686, 2006Tradução . . Disponível em: https://doi.org/10.1177/0269881106060967. Acesso em: 21 maio 2024.APA
Zuardi, A. W., Hallak, J. E. C., Dursun, S. M., Morais, S. L., Sanches, R. F., Musty, R. E., & Crippa, J. A. de S. (2006). Cannabidiol monotherapy for treatment-resistant schizophrenia. Journal of Phychopharmacology, 20( 5), 683-686. doi:10.1177/0269881106060967NLM
Zuardi AW, Hallak JEC, Dursun SM, Morais SL, Sanches RF, Musty RE, Crippa JA de S. Cannabidiol monotherapy for treatment-resistant schizophrenia [Internet]. Journal of Phychopharmacology. 2006 ; 20( 5): 683-686.[citado 2024 maio 21 ] Available from: https://doi.org/10.1177/0269881106060967Vancouver
Zuardi AW, Hallak JEC, Dursun SM, Morais SL, Sanches RF, Musty RE, Crippa JA de S. Cannabidiol monotherapy for treatment-resistant schizophrenia [Internet]. Journal of Phychopharmacology. 2006 ; 20( 5): 683-686.[citado 2024 maio 21 ] Available from: https://doi.org/10.1177/0269881106060967